Dow to Proceed with Polyols Capacity Expansion in Terneuzen

Dow Polyurethanes, a business group of The Dow Chemical Company, has announced that it will move forward with the detailed engineering phase of the name-plate capacity expansion of its polyols plant in Terneuzen, The Netherlands.

The company has selected Jacobs Engineering, a design contract firm based in The Netherlands, to handle the engineering needs of the project.

Dow announced in March of this year that it had completed a feasibility study to increase polyols production at the facility by 180 kilotons per annum (KTA). Dow expects to begin work on the expansion in early 2008, with completion shortly thereafter.

“This significant polyols expansion underscores Dow’s commitment to strengthen its position in Europe, with a focus on driving the growth of its Performance businesses throughout the region,” said Doug Warner, business director for polyols, Dow Polyurethanes. “Our decision to undertake an expansion at this facility is driven by demand for Dow polyols in downstream markets and strong customer interest in our specialty polyols and polyurethanes systems products.”

Raw materials for the polyols produced at the site will be sourced from the 300 KTA joint Dow and BASF hydrogen peroxide to propylene oxide (HPPO) facility currently under construction in Antwerp, Belgium. That facility is scheduled to come online in 2008. Propylene oxide (PO) is a raw material used in the manufacture of polyols.

Polyols are used to make polyurethanes products and systems formulations for a variety of end-use markets including automotive, appliances, coatings, adhesives, sealants, elastomers, construction, footwear, furniture and bedding.

http://www.dow.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.